A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
about
Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza virusesA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininRecombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccineProgress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionPseudotype-based neutralization assays for influenza: a systematic analysis.Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus.A high-affinity CDR-grafted antibody against influenza A H5N1 viruses recognizes a conserved epitope of H5 hemagglutinin.Influenza virus antigenicity and broadly neutralizing epitopes.Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody.Identification of a Highly Conserved Epitope on Avian Influenza Virus Non-Structural Protein 1 Using a Peptide MicroarrayComprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infectionInfluenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus.Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor.Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.Efficient cell pairing in droplets using dual-color sorting.Influenza glycoproteins: Hemagglutinin and neuraminidaseComplementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodiesThe Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral Pathogenesis
P2860
Q26825532-DDF3B068-76EE-4472-8888-D6D526023EF2Q27679987-5FF0FE82-6ADA-4464-9FD4-DB6E6F40C5CFQ30221529-4380ECEF-400F-439F-B6C3-F54FA00414DAQ30366891-7F5FB894-B49A-497A-83AB-CAE9B6E84F62Q30371674-EDEDAFBB-5366-43A0-AFF5-5F9B8F42AB2BQ30374662-C1E5AE43-2261-49AC-80F9-65F7C5A845BCQ30430279-4740BC8B-3122-4A27-9DA0-537DD125F064Q30535722-34203904-BDE6-4A2E-B5F5-5A4B660E0986Q33724743-0B6DC538-AFC7-4DC5-AB06-68341AD08C90Q34291530-13B16FE1-F3D6-4E3B-ACD2-39DF5F1C08C6Q35099676-82AB6D73-04A6-4883-9713-3A78C85ABCBDQ35685270-AE2F91C6-6657-4650-A35D-61E2D9C48CC0Q35909991-53E19512-7A9C-4B1C-86E8-D2576B086969Q35944473-691C1CD6-703D-4DDF-8B0C-C43423F4D8F7Q36392511-B57FF7E7-7808-4600-B59D-4268C1438CEFQ36432748-8E50CF09-C837-412E-9C55-3832091B5B8BQ36667857-00373C70-955A-4262-84C2-B93BD7BC20B2Q37141589-3D2C756A-E070-45F9-A27A-E61906FDECF9Q40244403-6898A870-1B6E-4136-B5AF-2527EF30D672Q40248004-0191665F-CD2E-4DB7-BA4E-2395ABB6DD9FQ40279321-501DA145-F6C3-4D07-956A-84A55401A14FQ40683638-9135B5C0-6E59-4769-8CF1-959D2802CB03Q42242342-D62C8C88-4CAE-460B-85FB-60A6F3D2637AQ51484082-8A46A188-5C50-43B1-8DA0-4A599099B9A8Q57884070-D3984D2A-72A0-48BB-83B2-440D9D013B07Q58696897-F0A2A92E-BBA6-4751-A18F-F91ADBAD4C70Q58788757-0506169D-E538-430C-AB0B-53EBC60AF7EC
P2860
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A human antibody recognizing a ...... avian influenza H5N1 viruses.
@ast
A human antibody recognizing a ...... avian influenza H5N1 viruses.
@en
type
label
A human antibody recognizing a ...... avian influenza H5N1 viruses.
@ast
A human antibody recognizing a ...... avian influenza H5N1 viruses.
@en
prefLabel
A human antibody recognizing a ...... avian influenza H5N1 viruses.
@ast
A human antibody recognizing a ...... avian influenza H5N1 viruses.
@en
P2093
P2860
P50
P356
P1433
P1476
A human antibody recognizing a ...... c avian influenza H5N1 viruses
@en
P2093
Boping Zhou
Cheguo Tsai
Guiqing Wang
Guoliang Zhang
Jarrod Voss
John J Skehel
Lesley Calder
Linqi Zhang
P2860
P304
P356
10.1128/JVI.06665-11
P577
2012-01-11T00:00:00Z